Frequency and Severity of Hypoglycemia in Type 2 Diabetes Mellitus Patients Treated with a Sulfonylurea-Based Regimen at University-Affiliated Hospitals in Korea: The Naturalistic Evaluation of Hypoglycemic Events in Diabetic Subjects Study
- Authors
- Kim, Yon Su; Cho, Be Long; Kim, Woo Sik; Kim, Sang Hyun; Jung, In Hyeon; Sin, Won Yong; Choi, Dong Hoon; Lee, Sang Jae; Lim, Chun Soo; Kang, Kyung Pyo; Yu, Byung Yeon; Jeung, Wonju; Park, Chang Gyu
- Issue Date
- 7월-2019
- Publisher
- KOREAN ACAD FAMILY MEDICINE
- Keywords
- Glycated Hemoglobin A; Hypoglycemia; Sulfonylurea; Type 2 Diabetes Mellitus; Metformin
- Citation
- KOREAN JOURNAL OF FAMILY MEDICINE, v.40, no.4, pp.212 - 219
- Indexed
- SCOPUS
KCI
- Journal Title
- KOREAN JOURNAL OF FAMILY MEDICINE
- Volume
- 40
- Number
- 4
- Start Page
- 212
- End Page
- 219
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/131408
- DOI
- 10.4082/kjfm.18.0051
- ISSN
- 2005-6443
- Abstract
- Background: We assessed the frequency and severity of hypoglycemia in type 2 diabetes mellitus patients treated with sulfonylurea monotherapy or sulfonylurea+metformin. Methods: We conducted a retrospective, observational, cross-sectional study in 2011 and 2012 including patients with type 2 diabetes mellitus aged >= 30 years who were treated with >= 6 months of sulfonylurea monotherapy or sulfonylurea+metformin at 20 university-affiliated hospitals in Korea. At enrollment, glycated hemoglobin (HbA1c) was assessed; participants completed self-reported questionnaires describing hypoglycemia incidents over the past 6 months. A review of medical records up to 12 months before enrollment provided data on demographics, disease history, comorbidities, laboratory results, and drug usage. Results: Of 726 enrolled patients, 719 were included (55.6% male); 31.7% and 68.3% were on sulfonylurea monotherapy and sulfonylurea+metformin, respectively. Mean +/- standard deviation age was 65.9 +/- 10.0 years; mean HbA1c level was 7.0%+/- 1.0%; 77.8% of patients had hypertension (89.4% used antihypertensive medication); 60.5% had lipid disorders (72.5% used lipid-lowering medication); and 52.0% had one or more micro- or macrovascular diseases. Among patients with A1c measurement (n=717), 56.4% achieved therapeutic goals (HbA1c <7.0%); 42.4% (305/719) experienced hypoglycemia within 6 months of enrollment; and 38.8%, 12.9%, 12.7%, and 3.9% of patients experienced mild, moderate, severe, and very severe hypoglycemia symptoms, respectively. Several reported hypoglycemia frequency as 1-2 times over the last 6 months. The mean number of very severe hypoglycemia episodes was 3.5 +/- 5.5. Conclusion: Among type 2 diabetes mellitus patients treated with sulfonylurea-based regimens, glycemic levels were relatively well controlled but hypoglycemia remained a prevalent side effect.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.